| PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis S Bravaccini, M Puccetti, M Bocchini, S Ravaioli, M Celli, E Scarpi, ... Scientific reports 8 (1), 4254, 2018 | 154 | 2018 |
| Relevance of urine telomerase in the diagnosis of bladder cancer MA Sanchini, R Gunelli, O Nanni, S Bravaccini, C Fabbri, A Sermasi, ... Jama 294 (16), 2052-2056, 2005 | 137 | 2005 |
| Androgen receptor signaling pathways as a target for breast cancer treatment E Pietri, V Conteduca, D Andreis, I Massa, E Melegari, S Sarti, ... Endocrine-related cancer 23 (10), R485-R498, 2016 | 122 | 2016 |
| Palbociclib (PD 0332991): targeting the cell cycle machinery in breast cancer A Rocca, A Farolfi, S Bravaccini, A Schirone, D Amadori Expert opinion on pharmacotherapy 15 (3), 407-420, 2014 | 117 | 2014 |
| Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy SP Hong, TE Chan, Y Lombardo, G Corleone, N Rotmensz, S Bravaccini, ... Nature communications 10 (1), 3840, 2019 | 111 | 2019 |
| Nonsquamous, non-small-cell lung cancer patients who carry a double mutation of EGFR, EML4-ALK or KRAS: frequency, clinical-pathological characteristics, and response to therapy P Ulivi, E Chiadini, C Dazzi, A Dubini, M Costantini, L Medri, M Puccetti, ... Clinical lung cancer 17 (5), 384-390, 2016 | 102 | 2016 |
| Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data V Casadio, D Calistri, M Tebaldi, S Bravaccini, R Gunelli, G Martorana, ... Urologic oncology: seminars and original investigations 31 (8), 1744-1750, 2013 | 99 | 2013 |
| Microbiota-derived metabolites in tumor progression and metastasis T Rossi, D Vergara, F Fanini, M Maffia, S Bravaccini, F Pirini International Journal of Molecular Sciences 21 (16), 5786, 2020 | 87 | 2020 |
| Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or … M Branca, C Giorgi, D Santini, L Di Bonito, M Ciotti, A Benedetto, P Paba, ... Journal of clinical pathology 59 (1), 40-47, 2006 | 67 | 2006 |
| NMR-based metabolomic approach tracks potential serum biomarkers of disease progression in patients with type 2 diabetes mellitus L Del Coco, D Vergara, S De Matteis, E Mensà, J Sabbatinelli, ... Journal of clinical medicine 8 (5), 720, 2019 | 62 | 2019 |
| Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study P Ulivi, L Capelli, M Valgiusti, W Zoli, E Scarpi, E Chiadini, P Rosetti, ... Journal of Translational Medicine 10, 1-8, 2012 | 61 | 2012 |
| Urine telomerase: an important marker in the diagnosis of bladder cancer MA Sanchini, S Bravaccini, L Medri, R Gunelli, O Nanni, F Monti, ... Neoplasia 6 (3), 234-239, 2004 | 54 | 2004 |
| Progress with palbociclib in breast cancer: latest evidence and clinical considerations A Rocca, A Schirone, R Maltoni, S Bravaccini, L Cecconetto, A Farolfi, ... Therapeutic advances in medical oncology 9 (2), 83-105, 2017 | 49 | 2017 |
| Androgen receptor in breast cancer: A wolf in sheep’s clothing? A lesson from prostate cancer. S Salvi, M Bonafè, S Bravaccini Seminars in cancer biology 60, 132-137, 2020 | 46 | 2020 |
| Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells F Fabbri, G Brigliadori, P Ulivi, A Tesei, I Vannini, M Rosetti, S Bravaccini, ... Apoptosis 10, 1095-1103, 2005 | 45 | 2005 |
| Potential of telomerase expression and activity in cervical specimens as a diagnostic tool S Bravaccini, MA Sanchini, A Amadori, L Medri, L Saragoni, D Calistri, ... Journal of clinical pathology 58 (9), 911-914, 2005 | 43 | 2005 |
| Pancreatic cancer and cellular senescence: tumor microenvironment under the spotlight M Cortesi, M Zanoni, F Pirini, MM Tumedei, S Ravaioli, IG Rapposelli, ... International journal of molecular sciences 23 (1), 254, 2021 | 41 | 2021 |
| Urine telomerase activity for the detection of bladder cancer in females S Bravaccini, MA Sanchini, AM Granato, R Gunelli, O Nanni, D Amadori, ... The Journal of urology 178 (1), 57-61, 2007 | 40 | 2007 |
| Sorafenib for the treatment of breast cancer G Bronte, D Andreis, S Bravaccini, R Maltoni, L Cecconetto, A Schirone, ... Expert opinion on pharmacotherapy 18 (6), 621-630, 2017 | 38 | 2017 |
| Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations D Amadori, P Serra, S Bravaccini, A Farolfi, M Puccetti, E Carretta, L Medri, ... Breast cancer research and treatment 145, 177-183, 2014 | 38 | 2014 |
